Your browser doesn't support javascript.
loading
Key points to optimizing management and research on cancer-associated thrombosis
Carmona-Bayonas, A; Sánchez-Cánovas, M; Plasencia, JM; Custodio, A; Martínez de Castro, E; Virizuela, JA; Ayala de la Peña, F; Jiménez-Fonseca, P.
Affiliation
  • Carmona-Bayonas, A; Hospital Universitario Morales Meseguer. Hematology and Medical Oncology Department. Murcia. Spain
  • Sánchez-Cánovas, M; Hospital Universitario Morales Meseguer. Hematology and Medical Oncology Department. Murcia. Spain
  • Plasencia, JM; Hospital Universitario Morales Meseguer. Radiology Department. Murcia. Spain
  • Custodio, A; Hospital Universitario La Paz. Medical Oncology Department. Madrid. Spain
  • Martínez de Castro, E; Hospital Universitario Marqués de Valdecilla. Medical Oncology Department. Santander. Spain
  • Virizuela, JA; Hospital Universitario Virgen de Macarena. Medical Oncology Department. Seville. Spain
  • Ayala de la Peña, F; Hospital Universitario Morales Meseguer. Hematology and Medical Oncology Department. Murcia. Spain
  • Jiménez-Fonseca, P; Hospital Universitario Central de Asturias. Medical Oncology Department. Oviedo. Spain
Clin. transl. oncol. (Print) ; 20(2): 119-126, feb. 2018. tab, graf, ilus
Article in English | IBECS | ID: ibc-170551
Responsible library: ES1.1
Localization: BNCS
ABSTRACT
Despite the fact that thromboembolism is relatively common in oncology patients and that the interrelationship between thrombotic risk and specific mechanisms of tumorigenesis has long been known, many cardinal elements of prevention and treatment remain unresolved. Among the existing knowledge gaps, the need to validate the Ay scale and compare it to the Khorana index, develop, and standardize the use of predictive biomarkers for thrombotic risk, conduct clinical trials in thromboprophylaxis adapted to thrombotic risk, evaluate the efficacy and safety of direct anticoagulants, select patients who can benefit from anticoagulants for antitumor treatment, validate the EPIPHANY study decision tree to choose patients with low-risk pulmonary embolism, and accumulate more practical experience in special situations (rethrombosis, prolonged therapy beyond 6 months, etc.) are especially remarkable. These gray areas surrounding cancer-related thromboembolism explain why it continues to be a relatively common cause of serious events, at times interfering significantly with the development of new tumor-fighting strategies (AU)
RESUMEN
No disponible
Subject(s)
Search on Google
Collection: National databases / Spain Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.4: Reduce premature mortality due to noncommunicable diseases Database: IBECS Main subject: Thrombosis / Neoplasms Type of study: Diagnostic study / Etiology study / Prognostic study / Risk factors Limits: Humans Language: English Journal: Clin. transl. oncol. (Print) Year: 2018 Document type: Article Institution/Affiliation country: Hospital Universitario Central de Asturias/Spain / Hospital Universitario La Paz/Spain / Hospital Universitario Marqués de Valdecilla/Spain / Hospital Universitario Morales Meseguer/Spain / Hospital Universitario Virgen de Macarena/Spain
Search on Google
Collection: National databases / Spain Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.4: Reduce premature mortality due to noncommunicable diseases Database: IBECS Main subject: Thrombosis / Neoplasms Type of study: Diagnostic study / Etiology study / Prognostic study / Risk factors Limits: Humans Language: English Journal: Clin. transl. oncol. (Print) Year: 2018 Document type: Article Institution/Affiliation country: Hospital Universitario Central de Asturias/Spain / Hospital Universitario La Paz/Spain / Hospital Universitario Marqués de Valdecilla/Spain / Hospital Universitario Morales Meseguer/Spain / Hospital Universitario Virgen de Macarena/Spain
...